Focal Biosciences
Biotechnology company developing epigenetic modulators for cellular reprogramming and regenerative medicine applications.
Notes
Focal Biosciences is a biotechnology company focused on developing epigenetic modulators for cellular reprogramming. The company aims to harness the power of epigenetic modifications to reprogram cells for therapeutic applications in regenerative medicine.
The company operates in stealth mode with limited public information available. Their work involves developing small molecules and other approaches that can modify the epigenetic state of cells, potentially enabling cell fate transitions for therapeutic purposes.
Focal Biosciences is backed by Apollo Health Ventures, a venture capital firm focused on longevity and aging-related biotechnology investments.
Team
- Leadership team details not publicly available
Additional Research Findings
- Founded circa 2020
- Investor: Apollo Health Ventures
- Focus on epigenetic modulators for cellular reprogramming
- Limited public information available (stealth mode)
- Operating in regenerative medicine and longevity space
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Apollo Health Ventures | Dusseldorf, Germany / Boston, USA | biotech-focused | seedseries-a+1 | 15 |